ZSAN - Zosano Pharma's Board approves 1-for-35 reverse stock split

Zosano Pharma (NASDAQ:ZSAN) has announced a 1-for-35 reverse stock split of its common shares on Monday. That means every 35 shares of the company’s common stock will be automatically reclassified into 1 new share of the common stock. The shares will begin trading on a split-adjusted basis from markets open on Apr. 12, 2022. Stock is down 7% in pre-market trading. Earlier (Mar. 17): Zosano Pharma GAAP EPS of -$0.06 misses by $0.02, revenue of $0.09M misses by $1.39M

For further details see:

Zosano Pharma's Board approves 1-for-35 reverse stock split